Skip to main content

Elizabeth

Analyst

Goldman Sachs

Equibles does not estimate personal net worth.

About Elizabeth

Elizabeth is recorded as Analyst at Goldman Sachs. Elizabeth has spoken on 2 earnings calls across 2 companies, most recently for Taysha Gene Therapies, Inc. on November 12, 2026. Those appearances were for Taysha Gene Therapies, Inc. (TSHA) and Moderna, Inc. (MRNA). The companies whose calls Elizabeth spoke on are classified in the Healthcare sector.

Elizabeth on recent calls

“You mentioned that you will nominate an additional candidate targeting a CNS disorder and start preclinical activities in the first half of next year.”
Analyst — Goldman Sachs, Taysha Gene Therapies, Inc. Q3 FY2026 Earnings Call ·
“We wanted to ask about the flu and COVID combination vaccine and just given the RTF-41010, how should we think about this refiling and is there any read-through from a regulatory standpoint in the U.S. and then maybe just remind us of the study data that went into the submission initially and what the latest thinking…”
Analyst — Goldman Sachs, Moderna, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Goldman Sachs

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity